Hygromycin B inhibits synthesis of murine coronavirus RNA.
AUTOR(ES)
Macintyre, G
RESUMO
The aminoglycoside hygromycin B inhibits the infection of mouse hepatitis virus (MHV) A59 both in vitro and in vivo. In probing the mechanism by which hygromycin B exerts its antiviral effect, we describe here studies which point to inhibition of viral RNA synthesis as the key step in virus replication which is affected by the drug. Cells which are infected with MHV do not take up higher levels of hygromycin B than do uninfected ones. Comparative assays of MHV replication and MHV protein synthesis in the presence of hygromycin B and another aminoglycoside, neomycin, indicate that hygromycin B is the more-effective antiviral agent and that its antiviral activity likely does not involve phosphoinositide-mediated processes such as those inhibited by neomycin.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=245443Documentos Relacionados
- Cell-free translation of murine coronavirus RNA.
- Murine coronavirus packaging signal confers packaging to nonviral RNA.
- Hygromycin B therapy of a murine coronaviral hepatitis.
- Two murine coronavirus genes suffice for viral RNA synthesis.
- Coronavirus minus-strand RNA synthesis and effect of cycloheximide on coronavirus RNA synthesis.
